These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 8935886

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. New therapeutic agents marketed in 1993.
    Hussar DA.
    Pa Med; 1994 Apr; 97(4):12-6. PubMed ID: 8008381
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. New therapeutic agents marketed in 1993.
    Hussar DA.
    Pa Med; 1994 Jul; 97(7):16-8. PubMed ID: 7936695
    [Abstract] [Full Text] [Related]

  • 6. New therapeutic agents marketed in 1994.
    Hussar DA.
    Pa Med; 1995 May; 98(5):35-8. PubMed ID: 7792092
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Patent life of antiretroviral drugs approved in the US from 1987 to 2007.
    Rodriguez-Monguio R, Seoane-Vazquez E.
    AIDS Care; 2009 Jun; 21(6):760-8. PubMed ID: 19499381
    [Abstract] [Full Text] [Related]

  • 9. Market withdrawal of new molecular entities approved in the United States from 1980 to 2009.
    Qureshi ZP, Seoane-Vazquez E, Rodriguez-Monguio R, Stevenson KB, Szeinbach SL.
    Pharmacoepidemiol Drug Saf; 2011 Jul; 20(7):772-7. PubMed ID: 21574210
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Investigation on new molecular entities of drugs approved in three regions, Japan, U.S. and EU--common and preceding approvals in current 4 years].
    Saito M, Hirata-Koizumi M, Miyake S, Hasegawa R.
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2006 Jul; (124):80-2. PubMed ID: 17405529
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Canadian and US drug approval times and safety considerations.
    Rawson NS, Kaitin KI.
    Ann Pharmacother; 2003 Oct; 37(10):1403-8. PubMed ID: 14519031
    [Abstract] [Full Text] [Related]

  • 14. [Diagnostic kits in parasitology: which controls?].
    Rossi P.
    Parassitologia; 2004 Jun; 46(1-2):145-9. PubMed ID: 15305705
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Dissemination of information on unapproved/new uses for marketed drugs, biologics, and devices--FDA. Final rule.
    Fed Regist; 1998 Nov 20; 63(224):64556-88. PubMed ID: 10339052
    [Abstract] [Full Text] [Related]

  • 19. Dissemination of information on unapproved/new uses for marketed drugs, biologics, and devices--FDA. Proposed rule.
    Fed Regist; 1998 Jun 08; 63(109):31143-61. PubMed ID: 10180130
    [Abstract] [Full Text] [Related]

  • 20. Between a rock and a hard place.
    Demaria AN.
    J Am Coll Cardiol; 2010 Nov 16; 56(21):1761-2. PubMed ID: 21070930
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.